Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Fort Hood Shooting: A Wake-up Call for Lawmakers— Investigating Psychiatric Drugs & Violence Connection is Long Overdue Says Mental Health Watchdog
  • USA - English


News provided by

Citizens Commission on Human Rights International

Apr 04, 2014, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Los Angeles, California (PRWEB) April 04, 2014 -- Violence and psychiatric drugs—a deadly formula America is becoming too intimately familiar with and, the mental health watchdog group, Citizens Commission on Human Rights (CCHR) says that rather than continually send heartfelt condolences to the families of the victims, it is time for lawmakers to investigate the connection between prescription psychiatric drugs and violence.

America learned within hours of the April 2nd shooting at Ft. Hood that four people were dead (including the shooter) and 16 had been wounded in the attack. The shooter, 34-year old Army Specialist, Ivan Lopez, served in Iraq for four months in 2011 and according to The New York Times, Secretary of the Army, John McHugh, said Lopez had been "examined by a psychiatrist within the last month, but showed no signs that he might commit a violent act." Secretary McHugh further explained to the Senate Armed Services Committee that Lopez "had been prescribed Ambien, a sleep aid, and other medication to treat anxiety and depression."[1]

CCHR says this sounds sadly familiar to the September 2013 Washington Navy Yard attack by Aaron Alexis, who had been taking the antidepressant, Trazadone, when he killed twelve innocent people. [2]

CCHR continues that, “psychiatric treatment, in the form of prescription mind-altering drugs, once again is connected to a mass shooting. Yet, despite data showing a connection between psychiatric mind-altering drugs and violence, lawmakers have yet to investigate the connection.”[3]

“The lack of Congressional action isn't a matter of being unaware of the connection,” states CCHR. For example, in response to the Navy Yard Shooting, U.S. Representative Jeff Miller (R-Fla.), Chairman of the House Committee on Veterans' Affairs, made the connection between psychiatric drugs and Alexis's attack almost immediately. During an interview with a Washington, D.C., Radio station, WTOP, Chairman Miller said "one of the medications that Alexis received does have a side effect that could in fact have been a problem." At that time, Chairman Miller directed the Department of Veterans' Affairs to save all records relating to the 34-year old Alexis. The reason for this action said Chairman Miller was to "make sure everything that could have been done was done, and that the VA does not do something to change the storyline." [4]

While the committee's investigation into the VA's treatment of Alexis is on-going, much more needs to be done and quickly.[5]

The military long has been aware of the increasing number of military suicides and last August released the findings of the Department of Defense (DOD) 2013 Study title "Risk Factors Associated With Suicide in Current and Former US Military Personnel." Although the study was based on a questions posed to current and former military personnel, nowhere in the study do the words "drugs" or "medication" appear. The DOD study did conclude in part that, "the most important finding was that mental health problems, including manic-depressive disorder, depression, and alcohol-related problems, were significantly associated with an increase in the risk of suicide." [6] Yet, the study questionnaire did not ask respondents to provide information about psychiatric drugs they had been prescribed.

While psychiatric drug information did not make it onto the questionnaire, CCHR explains that there is ample data to support an investigation into the increasing number of psychotropic drugs prescribed to military personnel and the part the drugs may play in the recurring violence.

• Since 2002, the suicide rate in the U.S. military has almost doubled.[7]

• From 2009 to 2012, more U.S. Soldiers died by suicide than from traffic accidents, heart disease, cancer and homicide.[8]

• In 2012, there were 349 suicides among active duty military personnel - more than were killed in combat in Iraq and Afghanistan.[9]

• Veterans are killing themselves at a rate of 22 a day - one every 65 minutes.[10]

• The U.S. Department of Defense now spends $2 billion a year on mental health alone.[11]

• The Veterans Administration's mental health budget has soared from less than $3 billion in 2007 to nearly $7 billion in 2014.[12]

• From 2005 to 2011, the Department of Defense and the Veterans Administration increased their prescriptions of psychiatric drugs by nearly seven times. That's more than thirty times faster than the civilian rate.[13]

• One in six American service members is on at least one psychiatric drug.[14]

• Thirty-seven percent of recent war veterans are being diagnosed with PTSD and 80 percent are of those are prescribed a psychiatric drug.[15]

Add to the above data the fact that there are 22 international drug regulatory warnings on psychiatric drugs, citing effects of mania, hostility, violence and even homicidal ideation. And, the Food and Drug Administration (FDA) MedWatch system on psychiatric drugs reveals that between 2004 and 2012, there have been 14,773 reports on psychiatric drugs causing violent side effects including: 1,531 cases of homicidal ideation/homicide, 3,287 cases of mania & 8,219 cases of aggression.[16]

While offering his condolences, President Obama provided assurances that "we are going to do everything we can to make sure that the community at Fort Hood has what it needs to deal with the current situation, but also any potential aftermath."[17]

CCHR says that given that the common response to mass shootings is a rush to deliver increased mental health services, which more often than not includes psychiatric drugs, there is no time to waste. Lawmakers must immediately begin an investigation into the possibility that the psychiatric drugs provided as treatment may actually be contributing to the increased violence. There are numerous medical experts that do not have conflicts of interest and could provide lawmakers with valuable information.

Watch CCHR's Hidden Enemy documentary here.

About Citizens Commission on Human Rights: CCHR is a non-profit, non-political, non-religious mental health watchdog. Its mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. CCHR has helped to enact more than 150 laws protecting individuals from abusive or coercive mental health practices.

--

[1] David Montgomery, Manny Fernandez and Timothy Williams, "Fort Hood Gunman Was Being Treated for Depression," The New York Times, April 3, 2014, nytimes.com/2014/04/04/us/fort-hood-shooting.html?_r=2

[2] Lena H. Sun, "Trazodone antidepressant, used by Aaron Alexis, described as ‘very safe’" The Washington Post, Sept. 18, 2014, washingtonpost.com/national/health-science/trazodone-antidepressant-used-by-aaron-alexis-described-as-very-safe/2013/09/18/4336c044-20ae-11e3-966c-9c4293c47ebe_story.html

[3] "The Adverse Event Reporting System (AERS): Older Quarterly Data Files," U.S. Food and Drug Administration, fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm083765.htm; 22 international warnings compiled from the US FDA, fda.gov/Safety/MedWatch; US DEA, justice.gov/dea/‎; Health Canada, hc-sc.gc.ca/index-eng.php; Japan Ministry of Health, Labour and Welfare, mhlw.go.jp/english/; European Medicines Agency, ema.europa.eu/ema/; Australia’s Therapeutic Goods Administration, tga.gov.au; UK’s Medicines and Healthcare products Regulatory Agency, mhra.gov.uk/‎

[4] John Aaron, "Congressman: Alexis' drug may have had 'problem' side effect," WTOP, 103.5 FM, Sept. 201, 2013, wtop.com/1385/3458698/Alexis-prescription-may-have-had-problem-side-effect

[5] "Congress Seeking Shooter's Veterans Records," NBC Washington, Sept. 17, 2013, [6 Cynthia A. LeardMann, MPH; Teresa M. Powell, MS; et al., "Risk Factors Associated With Suicide in Current and Former US Military Personnel," Journal of the American Medical Association, Vol. 310, No. 5, August 7, 2013, jama.jamanetwork.com/article.aspx?articleid=1724276

[7] “Baffling Rise in Suicides Plagues the U.S. Military,” The New York Times, nytimes.com/2013/05/16/us/baffling-rise-in-suicides-plagues-us-military.html?pagewanted=all, May 15, 2013.

[8] Gregg Zoroya, "Suicides No. 2 cause of death in military," USA TODAY, June 14, 2012, usatoday30.usatoday.com/news/military/story/2012-06-13/military-suicides/55585182/1

[9] Bill Briggs, "Military suicide rate hit record high in 2012," NBC News, Jan. 14, 2013, usnews.nbcnews.com/_news/2013/01/14/16510852-military-suicide-rate-hit-record-high-in-2012?lite

[10] Moni Basu, "Why suicide rate among veterans may be more than 22 a day," CNN, Nov. 14, 2013, cnn.com/2013/09/21/us/22-veteran-suicides-a-day/

[11] Martha Thompson & Nancy Gibbs, "The War On Suicide?" Time Magazine, July 23, 2012, content.time.com/time/magazine/article/0,9171,2119337,00.html

[12] John Ramsey, "The Last Battle: Steven Chadduck lost his home and nearly committed suicide while waiting for help for PTSD," Fayottesville Observer, Sept. 24, 2012, fayobserver.com/military/article_a0699933-cac5-5ced-8616-f01eef305f16.html; Patricia Kime, "Budget plan gives VA big funding boost for veterans care," Army Times, Apr. 10, 2013, writer armytimes.com/article/20130410/NEWS/304100023/Budget-plan-gives-VA-big-funding-boost-veterans-care

[13] “War on Drugs,” The New York Times, April 6, 2013, nytimes.com/2013/04/07/opinion/sunday/wars-on-drugs.html

[14] “Medicating the Military,” Army Times, March 17, 2010, armytimes.com/article/20100317/NEWS/3170315/Medicating-military

[15] Susan Donaldson James, "Marines Battalion Mentally Upbeat, Despite Record Deaths," ABC News, April 15, 2011, abcnews.go.com/Health/camp-pendleton-marine-battalion-mentally-fit-deadliest-war/story?id=13377215; Mohamed S, Rosenheck RA, "Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection," Journal of Clinical Psychiatry, 2008, June Vol. 69, No. 6, pp. 959-65, ncbi.nlm.nih.gov/pubmed/18588361

[16] "The Adverse Event Reporting System (AERS): Older Quarterly Data Files," U.S. Food and Drug Administration, fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm083765.htm; 22 international warnings compiled from the US FDA, fda.gov/Safety/MedWatch; US DEA, justice.gov/dea/‎; Health Canada, hc-sc.gc.ca/index-eng.php; Japan Ministry of Health, Labour and Welfare, mhlw.go.jp/english/; European Medicines Agency, ema.europa.eu/ema/; Australia’s Therapeutic Goods Administration, tga.gov.au; UK’s Medicines and Healthcare products Regulatory Agency, mhra.gov.uk/‎

[17] Lindsay Holst, "The President Delivers a Statement About the Shooting at Fort Hood," whitehouse.gov/blog/2014/04/02/president-delivers-statement-about-shooting-fort-hood

Media Department, Citizens Commission on Human Rights International, http://www.cchrint.org, +1 323-467-4242, [email protected]

Modal title

There have been 22 international drug regulatory agency warnings issued on psychiatric drugs causing violent reactions. View graph for details.
There have been 22 international drug regulatory agency warnings issued on psychiatric drugs causing violent reactions. View graph for details.
There have been 10 studies in four countries on psychiatric drug-induced violence. View graph for details.
There have been 10 studies in four countries on psychiatric drug-induced violence. View graph for details.
Between 2004 and 2011, there were 12,755 reports to the U.S. FDA’s MedWatch system on psychiatric drugs causing violent side effects. View graph for details.
Between 2004 and 2011, there were 12,755 reports to the U.S. FDA’s MedWatch system on psychiatric drugs causing violent side effects. View graph for details.
Click here for a list of experts who can speak on the subject of psychiatric drugs and violence.
View PDF
Click here for a list of experts who can speak on the subject of psychiatric drugs and violence.
Click here for a list of noted national figures who have spoken out on psychiatric drugs and violence.
View PDF
Click here for a list of noted national figures who have spoken out on psychiatric drugs and violence.
There have been 22 international drug regulatory agency warnings issued on psychiatric drugs causing violent reactions. View graph for details. There have been 10 studies in four countries on psychiatric drug-induced violence. View graph for details. Between 2004 and 2011, there were 12,755 reports to the U.S. FDA’s MedWatch system on psychiatric drugs causing violent side effects. View graph for details. Click here for a list of experts who can speak on the subject of psychiatric drugs and violence. Click here for a list of noted national figures who have spoken out on psychiatric drugs and violence.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.